B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADRA2B

MOLECULAR TARGET

adrenoceptor alpha 2B

UniProt: P18089NCBI Gene: 15174 compounds

ADRA2B (adrenoceptor alpha 2B) is targeted by 74 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADRA2B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Yohimbine4.3778
2Clonidine3.5032
3Idazoxan3.5032
4Oxymetazoline3.5032
5Phentolamine3.3728
6Norepinephrine Precursor of epinephrine that is secreted by3.1422
7Epinephrine2.6413
8Mianserin2.208
9Phenylephrine2.087
10Piperoxan2.087
11Dexmedetomidine1.795
12Rilmenidine Oxazole derivative that acts as1.795
13Tolazoline1.795
14Quetiapine Fumarate1.614
15Naphazoline1.614
16Pergolide1.614
17Fluoxetine1.393
18Bromocriptine1.393
19Carvedilol1.393
20Dihydroergotamine1.393
21Tamsulosin1.393
22Amisulpride1.102
23Aripiprazole1.102
24Cabergoline1.102
25Dihydroergotamine1.102
26Guanfacine1.102
27Lisuride1.102
28Phenoxybenzamine1.102
29cbd0.691
30Duloxetine Hydrochloride0.691
31Sertraline0.691
32vinpocetine0.691
33Ascorbic Acid0.691
34Afatinib0.691
35Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent0.691
36Amoxapine0.691
37Ascorbic Acid0.691
38Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
39Buspirone0.691
40cannabidiol0.691
41Cefepime0.691
42Celecoxib0.691
43Chlorhexidine0.691
44Chlorpheniramine0.691
45Dihydroergocornine0.691
46Domperidone0.691
47Ergotamine0.691
48Fentanyl0.691
49Fluspirilene0.691
50Guanabenz0.691

Showing top 50 of 74 compounds. Use the BiohacksAI search to explore all ADRA2B modulators.

About ADRA2B as a Drug Target

ADRA2B (adrenoceptor alpha 2B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 74 compounds with documented ADRA2B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADRA2B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.